Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Schultz

Showing results (241-250 of 250) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 250 results.
Nature|February 21, 2014
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cellsMagdalena Paolino, Axel Choidas, Stephanie Wallner, et al.
Cell Metabolism|July 15, 2025
Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communicationJason C L Tong, Charlotte Frazer-Morris, Ali H Shilleh, et al.
Chemmedchem|September 30, 2017
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of CancerUlrich Lücking, Arne Scholz, Philip Lienau, et al.
Journal of Medicinal Chemistry|April 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing InhibitorsJonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht, et al.
Journal of Medicinal Chemistry|August 15, 2015
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design ApproachJulian Engel, André Richters, Matthäus Getlik, et al.
Nature Methods|November 8, 2016
Genetic code expansion for multiprotein complex engineeringChristine Koehler, Paul F Sauter, Mirella Wawryszyn, et al.
Chemical Science|December 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797SJonas Lategahn, Marina Keul, Philip Klövekorn, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2022
Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway diseaseCamilla Margaroli, Hamed Horati, Luke W Garratt, et al.
Nature|September 9, 2021
Bioaccumulation of therapeutic drugs by human gut bacteriaMartina Klünemann, Sergej Andrejev, Sonja Blasche, et al.
Pageof 25

Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Nature|February 21, 2014
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cellsMagdalena Paolino, Axel Choidas, Stephanie Wallner, et al.
Cell Metabolism|July 15, 2025
Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communicationJason C L Tong, Charlotte Frazer-Morris, Ali H Shilleh, et al.
Chemmedchem|September 30, 2017
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of CancerUlrich Lücking, Arne Scholz, Philip Lienau, et al.
Journal of Medicinal Chemistry|April 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing InhibitorsJonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht, et al.
Journal of Medicinal Chemistry|August 15, 2015
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design ApproachJulian Engel, André Richters, Matthäus Getlik, et al.
Nature Methods|November 8, 2016
Genetic code expansion for multiprotein complex engineeringChristine Koehler, Paul F Sauter, Mirella Wawryszyn, et al.
Chemical Science|December 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797SJonas Lategahn, Marina Keul, Philip Klövekorn, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 22, 2022
Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway diseaseCamilla Margaroli, Hamed Horati, Luke W Garratt, et al.
Nature|September 9, 2021
Bioaccumulation of therapeutic drugs by human gut bacteriaMartina Klünemann, Sergej Andrejev, Sonja Blasche, et al.
Pageof 25